Amikacin VHA Plus 112180 1000 mg (100 mg/mL) in 0.45% sodium chloride injection SP 0.4 mL/min Aztreonam Bristol-Myers Squibb 9H28459 2 g (200 mg/mL) in 0.45% sodium chloride injection SP 0.4 mL ...

an aminoglycoside or aztreonam. Metronidazole is added if anaerobic activity is required for bariatric surgeries involving the ileum. Intravenous is preferred over topical, subcutaneous or ...

The drug – a combination of beta-lactam antibiotic aztreonam with beta-lactamase inhibitor avibactam – is the first monobactam/β-lactamase inhibitor combination to be cleared in the US for ...

Antimicrobial resistance (AMR) is a critical global issue, contributing to increased morbidity and mortality, prolonged hospital ...

EMBLAVEO 将于 2025 年第三季度在美国投入商业使用。 参考来源：‘US FDA approves Emblaveo™ (aztreonam and avibactam) for the treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

针对产金属 β- 内酰胺酶（MBL）铜绿假单胞菌感染治疗难题，研究用头孢吡肟 / 齐德巴坦治疗患者获临床和微生物学治愈 ...

• In February 2025, AbbVie announced that the FDA had approved Emblaveo (aztreonam and avibactam) in combination with ...

Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in ...

The following table presents notable drug approvals of February 2025. Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive ...

A roundup of the most newsworthy healthcare press releases from PR Newswire, including business strategies shaping the future ...